Pharmacogenetic applications of the Human Genome project
- 1 March 2001
- journal article
- editorial
- Published by Springer Nature in Nature Medicine
- Vol. 7 (3) , 281-283
- https://doi.org/10.1038/85411
Abstract
No abstract availableKeywords
This publication has 10 references indexed in Scilit:
- A map of human genome sequence variation containing 1.42 million single nucleotide polymorphismsNature, 2001
- Initial sequencing and analysis of the human genomeNature, 2001
- Apolipoprotein E Variation at the Sequence Haplotype Level: Implications for the Origin and Maintenance of a Major Human PolymorphismAmerican Journal of Human Genetics, 2000
- Complex promoter and coding region β 2 -adrenergic receptor haplotypes alter receptor expression and predict in vivo responsivenessProceedings of the National Academy of Sciences, 2000
- A Four Amino Acid Deletion Polymorphism in the Third Intracellular Loop of the Human α2C-Adrenergic Receptor Confers Impaired Coupling to Multiple EffectorsPublished by Elsevier ,2000
- Association of β2-Adrenoreceptor Variants with Bronchial HyperresponsivenessAmerican Journal of Respiratory and Critical Care Medicine, 2000
- Genotyping:The predictive power of haplotypes in clinical responsePharmacogenomics, 2000
- Heterogeneity of therapeutic responses in asthmaBritish Medical Bulletin, 2000
- Pharmacogenetic association between ALOX5 promoter genotype and the response to anti-asthma treatmentNature Genetics, 1999
- Oral Montelukast, Inhaled Beclomethasone, and Placebo for Chronic AsthmaAnnals of Internal Medicine, 1999